ACCURAY INC

ARAY

{{popupValue}}
{{popupSubtitle}}

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker
ARAY
CIK0001138723
SIC3841
SectorManufacturing
Industry CategoryMedical Equipment
Industry GroupSurgical, Medical, And Dental Instruments And Supplies

Contact

Address1240 DEMING WAY, MADISON, WI, 53717
Website accuray.com
Phone608-824-2800
CEOSuzanne C. Winter
Employees1,040

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement
Revenue$458.50 million
Pre-Tax Income$1.13 million
Net Income$-1.59 million
Net Income to Common$-1.59 million
EPS$-0.02
View All
Balance Sheet
Cash$57.42 million
Assets$470.24 million
Liabilities$389.07 million
Common Equity$81.17 million
Liabilities & Equity$470.24 million
View All
Cash Flow Statement
Calculations
NOPAT$-11.00 million
EBITDA$15.49 million
Price to EarningsN/A
Price to Book$2.10
ROE-2.52%
View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

Accuray (ARAY) Beats Q4 Revenue Estimates, BTIG Maintains Buy Rating

Accuray Incorporated (NASDAQ:ARAY) ranks among the top robotics to buy according to analysts. After Accuray Incorporated (NASDAQ:ARAY) reported fiscal fourth-quarter results and fiscal 2026 outlook, BTIG maintained its Buy rating on the radiation therapy company and increased its price target from $4 to $5 on August 14. Accuray’s fiscal fourth-quarter revenue of $127.5 million exceeded […]

Article Link

Are Investors Undervaluing Accuray Incorporated (NASDAQ:ARAY) By 34%?

NasdaqGS:ARAY 1 Year Share Price vs Fair Value Explore Accuray's Fair Values from the Community and select yours Key...

Article Link

Accuray Inc (ARAY) Q4 2025 Earnings Call Highlights: Resilient Growth Amid Geopolitical Challenges

Accuray Inc (ARAY) showcases strong service revenue and strategic refinancing, despite facing revenue declines in China and EIMEA regions.

Article Link

Accuray Stock Down as Q4 Earnings Miss Estimates, Revenues Down Y/Y

ARAY stock down after Q4 earnings miss estimates, with product sales hit by tariffs and regional demand softness.

Article Link

Accuray (ARAY) Reports Break-Even Earnings for Q4

Accuray (ARAY) delivered earnings and revenue surprises of -100.00% and +2.49%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Article Link